Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $196,015 | 105 | 88.4% |
| Travel and Lodging | $11,787 | 28 | 5.3% |
| Honoraria | $6,155 | 2 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,650 | 2 | 2.1% |
| Food and Beverage | $2,138 | 31 | 1.0% |
| Compensation for serving as faculty or as a speaker for a medical education program | $1,000 | 1 | 0.5% |
| Education | $0.55 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| QIAGEN, LLC | $88,500 | 56 | $0 (2024) |
| TAIHO ONCOLOGY, INC. | $26,655 | 14 | $0 (2023) |
| ABBVIE INC. | $19,160 | 11 | $0 (2024) |
| ARRAY BIOPHARMA INC | $18,162 | 14 | $0 (2022) |
| Ipsen Bioscience Inc | $11,496 | 8 | $0 (2021) |
| Amgen Inc. | $10,041 | 10 | $0 (2023) |
| F. Hoffmann-La Roche AG | $8,392 | 4 | $0 (2024) |
| Genentech, Inc. | $6,246 | 9 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $5,020 | 10 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $4,973 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $26,268 | 14 | QIAGEN, LLC ($18,000) |
| 2023 | $32,816 | 22 | QIAGEN, LLC ($18,000) |
| 2022 | $19,979 | 16 | Qiagen, LLC ($16,500) |
| 2021 | $41,017 | 23 | Qiagen, LLC ($19,500) |
| 2020 | $42,587 | 31 | QIAGEN, LLC ($16,500) |
| 2019 | $33,857 | 25 | Taiho Oncology, Inc. ($22,665) |
| 2018 | $12,492 | 19 | Genentech, Inc. ($5,142) |
| 2017 | $12,731 | 20 | Amgen Inc. ($6,611) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 11/05/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $3,420.00 | General |
| 09/10/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 08/20/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 07/09/2024 | ABBVIE INC. | — | Consulting Fee | Cash or cash equivalent | $3,987.50 | General |
| 07/03/2024 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $760.00 | General |
| 06/11/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 05/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $55.00 | General |
| 05/31/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 05/07/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/03/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 03/12/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 02/20/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/04/2024 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 12/06/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/27/2023 | Amgen Inc. | — | Consulting Fee | Cash or cash equivalent | $3,430.00 | General |
| 10/30/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 10/20/2023 | F. Hoffmann-La Roche AG | — | Consulting Fee | Cash or cash equivalent | $4,180.00 | General |
| 10/20/2023 | F. Hoffmann-La Roche AG | — | Food and Beverage | In-kind items and services | $31.75 | General |
| 10/04/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 09/06/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 08/03/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 07/10/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 06/06/2023 | QIAGEN, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 12 | 36 | $14,805 | $3,145 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 36 | $14,805 | $3,145 | 21.2% |
About Ryan Corcoran, MD, PHD
Ryan Corcoran, MD, PHD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1508993957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ryan Corcoran, MD, PHD has received a total of $221,746 in payments from pharmaceutical and medical device companies, with $26,268 received in 2024. These payments were reported across 170 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($196,015).
As a Medicare-enrolled provider, Corcoran has provided services to 12 Medicare beneficiaries, totaling 36 services with total Medicare billing of $3,145. Data is available for 1 year (2022–2022), covering 1 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Boston, MA
- Active Since 02/27/2007
- Last Updated 08/16/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508993957
Products in Payments
- Prolia (Biological) $5,501
- BRAFTOVI (Drug) $5,355
- MEKTOVI (Drug) $4,006
- OPDIVO (Biological) $2,831
- LONSURF (Drug) $2,640
- Enhertu (Drug) $2,205
- ONIVYDE (Drug) $2,121
- POC Urinalysis Assessories (Device) $2,000
- ONCASPAR (Biological) $1,220
- KRAZATI (Drug) $1,079
- RDI Research (Device) $528.16
- YERVOY (Biological) $350.00
- CD cobas Reagents (Device) $62.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M